Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):6812-6817. doi: 10.1073/pnas.1701002114. Epub 2017 Jun 12.

Abstract

Oncolytic virotherapy is a treatment modality that uses native or genetically modified viruses that selectively replicate in and kill tumor cells. Viruses represent a type of pathogen-associated molecular pattern and thereby induce the up-regulation of dozens of cytokines via activating the host innate immune system. Second mitochondria-derived activator of caspases (Smac) mimetic compounds (SMCs), which antagonize the function of inhibitor of apoptosis proteins (IAPs) and induce apoptosis, sensitize tumor cells to multiple cytokines. Therefore, we sought to determine whether SMCs sensitize tumor cells to cytokines induced by the oncolytic M1 virus, thus enhancing a bystander killing effect. Here, we report that SMCs potentiate the oncolytic effect of M1 in vitro, in vivo, and ex vivo. This strengthened oncolytic efficacy resulted from the enhanced bystander killing effect caused by the M1 virus via cytokine induction. Through a microarray analysis and subsequent validation using recombinant cytokines, we identified IL-8, IL-1A, and TRAIL as the key cytokines in the bystander killing effect. Furthermore, SMCs increased the replication of M1, and the accumulation of virus protein induced irreversible endoplasmic reticulum stress- and c-Jun N-terminal kinase-mediated apoptosis. Nevertheless, the combined treatment with M1 and SMCs had little effect on normal and human primary cells. Because SMCs selectively and significantly enhance the bystander killing effect and the replication of oncolytic virus M1 specifically in cancer cells, this combined treatment may represent a promising therapeutic strategy.

Keywords: SMAC mimetics; bystander killing effect; oncolytic virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / immunology
  • Bystander Effect / drug effects*
  • Bystander Effect / immunology
  • Cell Line, Tumor
  • Cytokines / immunology
  • Humans
  • Mice
  • Neoplasms, Experimental / immunology
  • Neoplasms, Experimental / pathology
  • Neoplasms, Experimental / therapy*
  • Oligopeptides / pharmacology*
  • Oncolytic Viruses / physiology*
  • Peptidomimetics / pharmacology*
  • Virus Replication / drug effects*

Substances

  • Cytokines
  • Oligopeptides
  • Peptidomimetics
  • SMAC peptide